Half-year report · Q2
6951.TEDINET S100UO4D
Period2024-04-01 → 2024-09-30
Filed2024-11-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥87.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥174.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥68.7bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥15.8bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥8.3bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥14.1bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥30.0bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.2bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥14.1bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥10.2bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥10.9bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥21.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥7.5bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥10.9bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥7.5bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥229.7bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥230.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥204.8bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥98.1bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥104.7bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥131.6bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥125.5bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥109.4bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥39.6bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥31.5bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥37.7bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.8bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.2bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.0bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥17.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥15.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.6bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥18.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥7.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥798m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥213.6 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥424.92 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥147.16 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 57.3% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.5% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.4% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥3.2bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥28.7bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥28.7bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.6bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥6.4bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥6.4bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥394m |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥52.2bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥52.2bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥4.0bn |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥87.2bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥87.2bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥19.0bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥2.9bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥17.2bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥17.2bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥7.0bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥7.4bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥7.4bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥539m |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥44.1bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥44.1bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥3.7bn |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥68.7bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥68.7bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥11.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 540
| Item | Context | Value | Unit |
|---|---|---|---|
| Research and development expenses sga | Prior1YTDDuration | 5260000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 6140000000 | JPY |
| Other sga | Prior1YTDDuration | 19488000000 | JPY |
| Other sga | CurrentYTDDuration | 21138000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 24748000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 27279000000 | JPY |
| Operating income | Prior1YTDDuration | 8291000000 | JPY |
| Operating income | CurrentYTDDuration | 15817000000 | JPY |
| Interest income noi | Prior1YTDDuration | 69000000 | JPY |
| Interest income noi | CurrentYTDDuration | 91000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 93000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 117000000 | JPY |
| Revenue from acceptance of development services noi | Prior1YTDDuration | 105000000 | JPY |
| Revenue from acceptance of development services noi | CurrentYTDDuration | 92000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 1503000000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | － | JPY |
| Equity in earnings of affiliates noi | Prior1YTDDuration | 118000000 | JPY |
| Equity in earnings of affiliates noi | CurrentYTDDuration | 254000000 | JPY |
| Other noi | Prior1YTDDuration | 131000000 | JPY |
| Other noi | CurrentYTDDuration | 163000000 | JPY |
| Non operating income | Prior1YTDDuration | 2022000000 | JPY |
| Non operating income | CurrentYTDDuration | 720000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 27000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 58000000 | JPY |
| Loss on sales of accounts receivable noe | Prior1YTDDuration | 0 | JPY |
| Loss on sales of accounts receivable noe | CurrentYTDDuration | 1000000 | JPY |
| Loss on insurance cancellation noe | Prior1YTDDuration | 41000000 | JPY |
| Loss on insurance cancellation noe | CurrentYTDDuration | 49000000 | JPY |
| Foreign exchange losses noe | Prior1YTDDuration | － | JPY |
| Foreign exchange losses noe | CurrentYTDDuration | 2266000000 | JPY |
| Other noe | Prior1YTDDuration | 51000000 | JPY |
| Other noe | CurrentYTDDuration | 62000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 121000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 2438000000 | JPY |
| Ordinary income | Prior1YTDDuration | 10192000000 | JPY |
| Ordinary income | CurrentYTDDuration | 14099000000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 153000000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 5000000 | JPY |
| Gain on sales of subsidiaries and affiliates stocks ei | Prior1YTDDuration | 24000000 | JPY |
| Gain on sales of subsidiaries and affiliates stocks ei | CurrentYTDDuration | － | JPY |
| Extraordinary income | Prior1YTDDuration | 177000000 | JPY |
| Extraordinary income | CurrentYTDDuration | 5000000 | JPY |
| Loss on sales of noncurrent assets el | Prior1YTDDuration | 0 | JPY |
| Loss on sales of noncurrent assets el | CurrentYTDDuration | 3000000 | JPY |
| Loss on retirement of noncurrent assets el | Prior1YTDDuration | 5000000 | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration | 5000000 | JPY |
| Loss on valuation of investment securities el | Prior1YTDDuration | 123000000 | JPY |
| Loss on valuation of investment securities el | CurrentYTDDuration | － | JPY |
| Extraordinary loss | Prior1YTDDuration | 128000000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 8000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |